SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-237342
Filing Date
2022-09-02
Accepted
2022-09-02 09:44:01
Documents
7
Period of Report
2022-09-02

Document Format Files

Seq Description Document Type Size
1 6-K d316499d6k.htm 6-K 11515
2 EX-99.1 d316499dex991.htm EX-99.1 24317
3 EX-99.2 d316499dex992.htm EX-99.2 30698
4 GRAPHIC g316499dsp04a.jpg GRAPHIC 1307
5 GRAPHIC g316499dsp05a1.jpg GRAPHIC 1568
6 GRAPHIC g316499g0902145440465.jpg GRAPHIC 2601
7 GRAPHIC g316499g0902162935896.jpg GRAPHIC 2512
  Complete submission text file 0001193125-22-237342.txt   79285
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221223458
SIC: 2834 Pharmaceutical Preparations